Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?

By S. Sabharwal, P. Schumacker. Nature Reviews. Cancer, 2014

1,457 citations recorded by the source corpus.

Mitochondria cooperate with their host cells by contributing to bioenergetics, metabolism, biosynthesis, and cell death or survival functions. Reactive oxygen species (ROS) generated by mitochondria participate in stress signalling in normal cells but also contribute to the initiation of nuclear or mitochondrial DNA mutations that promote neoplastic transformation. In cancer cells, mitochondrial ROS amplify the tumorigenic phenotype and accelerate the accumulation of additional mutations that lead to metastatic behaviour. As mitochondria carry out important functions in normal cells, disabling their function is not a feasible therapy for cancer. However, ROS signalling contributes to proliferation and survival in many cancers, so the targeted disruption of mitochondria-to-cell redox communication represents a promising avenue for future therapy.

Subfields: Education, General Social Sciences

View Paper: https://www.semanticscholar.org/paper/a963075057097c4b03abe2dc3b65948f12cfa5c6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. L. Galluzzi
  2. Guido Kroemer
  3. P. Porporato
  4. N. Filigheddu
  5. J. B. Pedro
  6. Jiaming Xie
  7. K. Avgerinos
  8. Yannan Yang

Citations in the corpus